Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer

Authors:

Abstract
Surgical resection of all visible tumors is associated with improved long-term survival and is a critical component of primary therapy for advanced-stage ovarian cancer.1 However, cytoreductive surgery carries a substantial risk of complications and death.2 We describe associations between age and 90-day postoperative mortality after cytoreductive surgery and investigate if administrating neoadjuvant chemotherapy diminishes the age-associated risk of 90-day mortality.